Logistics executives should consider these actions to address current challenges and join the ranks of supply-chain leaders.

Bill DeMartino, managing director for the Americas with Riskmethods, discusses how the coronavirus pandemic is impacting risk-management strategies, and whether companies were ready for the disruption that it has caused.

Daniel Hartnett, associate managing director of the Compliance Risk & Diligence Practice of Kroll, advises on the steps that pharmaceutical companies should take to reduce the risk of dealing with third parties, as they develop a COVID-19 vaccine.

A recent dispute between an importer and U.S. Customs and Border Protection (CBP) serves as a stark reminder that the “substantial transformation” test used to determine the country of origin of imported goods is far from straightforward.